Chapter 15: Antiparkinson Drugs - Nurselytic

Questions 13

ATI LPN

ATI LPN TextBook-Based Test Bank

Pharmacology and the Nursing Process 10th Edition Test Bank

Chapter 15 : Antiparkinson Drugs Questions

Question 1 of 5

Carbidopa-levodopa is prescribed for a patient with Parkinson's disease. The nurse informs the patient that which common adverse effects can occur with this medication?

Correct Answer: D

Rationale: Common adverse effects of carbidopa-levodopa include palpitations, hypotension, urinary retention, dyskinesias, and depression. The other options list effects more associated with other antiparkinson drugs.

Question 2 of 5

The nurse is assessing the medication history of a patient with a new diagnosis of Parkinson's disease. Which condition is a contraindication for the patient, who will be taking entacapone?

Correct Answer: C

Rationale: Entacapone is contraindicated in liver failure due to its hepatic metabolism, which could lead to toxicity. Glaucoma, seizure disorders, and benign prostatic hyperplasia are not absolute contraindications for entacapone.

Question 3 of 5

The nurse is developing a care plan for a patient who is taking an anticholinergic drug. Which human needs statement would be appropriate for this patient?

Correct Answer: B

Rationale: Anticholinergic drugs like benztropine can cause urinary retention and constipation, making altered urinary elimination the appropriate human needs statement. Diarrhea, infection risk, and sleep needs are not typically affected.

Question 4 of 5

A patient who has been on levodopa therapy for a year has a new order for a catechol ortho-methyltransferase (COMT) inhibitor as part of treatment for Parkinson's disease. The nurse recognizes that which of these is an advantage of this drug class?

Correct Answer: D

Rationale: COMT inhibitors like entacapone extend levodopa's duration, reducing the wearing-off phenomenon. They do not have a shorter duration, less GI distress, or slower onset compared to other antiparkinson drugs.

Question 5 of 5

A patient taking entacapone for the first time calls the clinic to report a dark discoloration of his urine. After listening to the patient, the nurse realizes that what is happening in this situation?

Correct Answer: A

Rationale: Entacapone commonly causes harmless dark discoloration of urine and sweat, which does not indicate an allergic reaction, interaction with tyramine-containing foods, or an excessive dose.

Access More Questions!

ATI LPN Basic


$89/ 30 days

 

ATI LPN Premium


$150/ 90 days

 

Similar Questions